Who Should Have an HbA1c? Development and External Validation of a Dysglycaemia Prediction Model Using Only Routinely Available Data

Background/Objectives: Whom to test for dysglycaemia is usually decided with a questionnaire, even when routine blood results are on file. We asked whether routine clinical data identify prevalent dysglycaemia better than the American Diabetes Association (ADA) risk test, how much of any advantage reflects refitting its items, and whether machine learning was needed. Methods: A model was developed in NHANES adults aged 20 years or older without diagnosed diabetes (2017–March 2020, n = 6649) and validated in the held-back August 2021–August 2023 cycle (n = 4826). The outcome was HbA1c 5.7% or higher. Forty-eight predictors from an encounter with a metabolic panel and a complete blood count were used; no glycaemic measurement entered any model. Penalised logistic regression, LightGBM, XGBoost, and the ADA risk test were compared by nested cross-validation. Performance estimates used survey weights, with confidence intervals from a bootstrap of primary sampling units within strata. Results: The regression reached an area under the curve of 0.810 (95% CI 0.788 to 0.830) internally and 0.818 (0.799 to 0.835) in the validation cycle, with calibration slopes of 1.04 and 1.08. Neither gradient-boosting model improved on it. In the development cycle, where the questionnaire could be scored, the regression exceeded it by 0.0694 (0.0493 to 0.0906; p < 0.001); refitting the ADA items accounted for 0.0150, and the remaining 0.0544 reflected adding 44 measurements and omitting three questionnaire items. At the questionnaire’s specificity, the model detected 10.6 more percentage points of cases (5.9 to 15.0). Conclusions: Among adults with a metabolic panel and a complete blood count on file, routine clinical data identified dysglycaemia better than the ADA questionnaire, and performance was reproduced in a later cycle. A transparent regression matched gradient boosting; most of the advantage came from the change in predictor set rather than from refitting the questionnaire’s items.

Authors

Institutions

Publication Details

Journal
Healthcare
Published
2026-11-13
DOI
https://doi.org/10.3390/healthcare14223903
Primary Topic
Artificial Intelligence in Healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Who Should Have an HbA1c? Development and External Validation of a Dysglycaemia Prediction Model Using Only Routinely Available Data

Enes ZAFER, Mehmet Yildiz
2 links
Healthcare
Artificial Intelligence in Healthcare
article

Who Should Have an HbA1c? Development and External Validation of a Dysglycaemia Prediction Model Using Only Routinely Available Data

Enes ZAFER, Mehmet Yildiz
article en

Abstract

Background/Objectives: Whom to test for dysglycaemia is usually decided with a questionnaire, even when routine blood results are on file. We asked whether routine clinical data identify prevalent dysglycaemia better than the American Diabetes Association (ADA) risk test, how much of any advantage reflects refitting its items, and whether machine learning was needed. Methods: A model was developed in NHANES adults aged 20 years or older without diagnosed diabetes (2017–March 2020, n = 6649) and validated in the held-back August 2021–August 2023 cycle (n = 4826). The outcome was HbA1c 5.7% or higher. Forty-eight predictors from an encounter with a metabolic panel and a complete blood count were used; no glycaemic measurement entered any model. Penalised logistic regression, LightGBM, XGBoost, and the ADA risk test were compared by nested cross-validation. Performance estimates used survey weights, with confidence intervals from a bootstrap of primary sampling units within strata. Results: The regression reached an area under the curve of 0.810 (95% CI 0.788 to 0.830) internally and 0.818 (0.799 to 0.835) in the validation cycle, with calibration slopes of 1.04 and 1.08. Neither gradient-boosting model improved on it. In the development cycle, where the questionnaire could be scored, the regression exceeded it by 0.0694 (0.0493 to 0.0906; p < 0.001); refitting the ADA items accounted for 0.0150, and the remaining 0.0544 reflected adding 44 measurements and omitting three questionnaire items. At the questionnaire’s specificity, the model detected 10.6 more percentage points of cases (5.9 to 15.0). Conclusions: Among adults with a metabolic panel and a complete blood count on file, routine clinical data identified dysglycaemia better than the ADA questionnaire, and performance was reproduced in a later cycle. A transparent regression matched gradient boosting; most of the advantage came from the change in predictor set rather than from refitting the questionnaire’s items.

HealthcareVol. 14(22)
Sakarya University (TR), Sakarya Eğitim ve Araştırma Hastanesi (TR), Giresun İl Sağlık Müdürlüğü (TR)
Good health and well-being
Artificial Intelligence in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon